Can enoxaparin be used for AFIB?

Can enoxaparin be used for AFIB? Conclusions—Enoxaparin is noninferior to UFHphenprocoumon for prevention of ischemic and embolic events, bleeding complications, and death in TEE-guided cardioversion of atrial fibrillation. What weight should I use for enoxaparin?

Can enoxaparin be used for AFIB?

Conclusions—Enoxaparin is noninferior to UFHphenprocoumon for prevention of ischemic and embolic events, bleeding complications, and death in TEE-guided cardioversion of atrial fibrillation.

What weight should I use for enoxaparin?

Patients at extremes of weight should have the dose of enoxaparin adjusted and anticoagulation should be monitored using the low molecular weight heparin assay. In clinical trials using enoxaparin for the treatment of DVT or PE, the 1 mg/kg Q 12 h dose was given to patients up to weights of approximately 150 kg.

How is enoxaparin calculated?

All treatment doses of enoxaparin are based on actual body weight. The patient must be weighed. Ensure the weight is clearly documented on the front of the Inpatient Medical Chart and in the medical notes. 1.1 Calculate the dose according to indication and renal function using actual body weight (table 1).

Is Lovenox dosed by weight?

The recommended dose of Lovenox is a single intravenous bolus of 30 mg plus a 1 mg/kg subcutaneous dose followed by 1 mg/kg administered subcutaneously every 12 hours (maximum 100 mg for the first two doses only, followed by 1 mg/kg dosing for the remaining doses) in patients with acute ST-segment elevation myocardial …

Why do you give heparin for atrial fibrillation?

In patients with atrial fibrillation that has persisted for more than 48 hours, heparin can be used to reduce the risk of thrombus formation and embolization until the warfarin level is therapeutic or cardioversion is performed.

How much heparin should I take for AFib?

From this dataset, initial heparin infusion rates of 9.7-11.0 U/kg/h without a bolus can result in therapeutic levels of anticoagulation in hospitalized patients with AF/AFL without increasing the risk of bleeding.

When should you not take enoxaparin?

You should not use enoxaparin if you are allergic to enoxaparin, heparin, benzyl alcohol, or pork products, or if you have: active or uncontrolled bleeding; or. if you had decreased platelets in your blood after testing positive for a certain antibody while using enoxaparin within the past 100 days.

How long can you be on enoxaparin?

The usual duration of administration is 7 to 10 days [see Clinical Studies]. A dose of Lovenox of 40 mg once a day subcutaneously may be considered for hip replacement surgery for up to 3 weeks.

What is the major side effect of enoxaparin?

The most common adverse reactions were bleeding, anemia, thrombocytopenia, elevation of serum aminotransferase, diarrhea, and nausea.

How long can you stay on Lovenox?

Is enoxaparin safe for patients with renal failure?

Enoxaparin, a low-molecular-weight form of heparin, is not approved for use in dialysis patients in the United States, because it is eliminated through the kidneys and could therefore accumulate and cause inadvertent bleeding. Accordingly, it is unknown if enoxaparin is as safe to prescribe as subcutaneous heparin for thromboprophylaxis in patients with chronic renal failure.

Can Lovenox be administered with heparin?

When heparin and Lovenox® are administered, heparin can be given either intravenously or subcutaneously — under the skin. Lovenox® is only injected subcutaneously. Frequent monitoring of blood clotting ability is required when the patient is using heparin, but with Lovenox® the monitoring can be much less frequent.

Can aspirin be taken for atrial fibrillation?

For decades the skeptical cardiologist and his cardiology brethren and sistren have prescribed aspirin to prevent stroke in patients with atrial fibrillation. For those patients with atrial fibrillation (AF) who were considered low risk it was felt that aspirin provided some benefit in preventing the clots that fly out of the heart (and land in arteries elsewhere in the body) at an acceptably low risk of bleeding.